Sanuwave appoints tech veteran Greg Bazar to its board

EDEN PRAIRIE, Minn. - Sanuwave Health, Inc. (NASDAQ:SNWV), a company specializing in advanced wound care products, has announced the appointment of Greg Bazar to its Board of Directors as of Tuesday. The appointment comes as the company shows strong market performance, with InvestingPro data revealing a remarkable 308% return over the past year, despite current trading levels suggesting the stock is overvalued. Bazar, known for his extensive background in engineering, computer science, cybersecurity, AI, and business intelligence, joins the board with a history of leading successful companies.

Bazar is currently the Chairman of the Board at Simpatico Systems, an IT and cybersecurity firm he founded. His previous roles include significant contributions to 3D-P, an intelligent connectivity provider, where he was instrumental in the company’s growth and eventual acquisition by Epiroc. Bazar’s career began at Caterpillar, where he focused on leveraging technology to enhance human innovation. He is a graduate of the Colorado School of Mines.

Sanuwave CEO Morgan Frank praised Bazar’s interdisciplinary expertise and cultural leadership, which align with the company’s future strategies. Frank expressed confidence that Bazar’s unique skill set would contribute to Sanuwave’s mission to revolutionize complex wound care.

In conjunction with Bazar’s appointment, the company also announced the departure of long-time board member Michael Stolarski, who intends to retire and pursue personal interests. Stolarski has been with Sanuwave since its early stages and is recognized for his significant contributions and spirit. He will continue to serve as a consultant to ensure a smooth transition.

Sanuwave Health is dedicated to the research and development of medical systems that activate biological responses for skin, musculoskeletal tissue, and vascular structure repair and regeneration. The company’s patented technology focuses on wound healing and extends to orthopedic, aesthetic, and cardiac conditions. While operating with moderate debt levels, InvestingPro analysis reveals additional insights about the company’s financial health and growth potential, with over 100 additional metrics and exclusive ProTips available to subscribers.

This announcement is based on a press release statement and includes forward-looking statements subject to risks and uncertainties. Sanuwave underlines that actual results may differ materially from those projected in the forward-looking statements due to various factors, including regulatory oversight and competition. The company does not assume any obligation to update these forward-looking statements.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.